Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: BRAVEHEART who wrote (621)	2/25/1999 8:02:00 PM
From: BRAVEHEART	Read Replies (2) \| Respond to of 1073

Hi Rick, I have been hoping for an opportunity to ask you if you have formed an opinion of MEDX from a science perspective. Also what is your take on the recent development. biz.yahoo.com Finally MEDX recently had a P-3 trial halted because of buffer concerns and adverse reactions. Are you familiar with any other similar cases. Are there typically alternatives as far as changing buffers. Is it a complex process and how would a company typically have to satisfy the FDA in order to restart Phase testing? Thanks Rick